Evidence map›Paper›PMID 41676926›Full record

SynthesisThe Cochrane database of systematic reviews2026

Training health professionals in smoking cessation.

Kelsey J Sharrad, Kristin V Carson-Chahhoud, Marjolein Ea Verbiest, Sarah Greenslade, Thomas Parkhouse, Willem Jj Assendelft, Mathilde R Crone, Jonathan Livingstone-Banks

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Kelsey J SharradAdelaide Medical School, The University of Adelaide, Adelaide, Australia.ORCID 0000-0002-0301-7161
Kristin V Carson-ChahhoudAdelaide Medical School, The University of Adelaide, Adelaide, Australia.ORCID 0000-0001-9966-9289
Marjolein Ea VerbiestCentre of Expertise Perspective in Health, Avans University of Applied Sciences, Breda, Netherlands.ORCID 0000-0003-3731-5295
Sarah GreensladeRespiratory and Sleep, Women's and Children's Hospital, Adelaide, Australia.ORCID 0009-0004-8516-7172
Thomas ParkhouseBristol Medical School, University of Bristol, Bristol, UK.
Willem Jj AssendelftDepartment of Primary and Community Care, 117 ELG, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands.ORCID 0000-0002-2966-3778
Mathilde R CroneDepartment of Health Promotion, Maastricht University, Maastricht, Netherlands.ORCID 0000-0003-1243-858X
Jonathan Livingstone-BanksNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-3757-5591

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleCigarette smoking is one of the leading causes of preventable death worldwide. There is good evidence that brief interventions by health professionals can increase smoking cessation attempts. However, as new studies become available, the effectiveness of these training programmes needs to be re-assessed to inform public policy, clinical care, and guideline recommendations. This is an update of a Cochrane review first published in 2000, and previously updated in 2012.

objectivesTo assess the effectiveness of training healthcare professionals to deliver smoking cessation interventions to their patients, and to assess the effects of training characteristics (such as content, setting, delivery, and intensity). SEARCH

methodsWe searched the following databases from inception to August 2024: Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE; Embase; PsycINFO; ClinicalTrials.gov (through CENTRAL); and the World Health Organization International Clinical Trials Registry Platform (through CENTRAL). We also searched the references of eligible studies. ELIGIBILITY CRITERIA: We included randomised trials in which the intervention was training of healthcare professionals in smoking cessation. We considered trials for inclusion if they reported outcomes for patient smoking at least six months after the intervention. Process outcomes needed to be reported. However, we excluded trials that reported effects only on process outcomes and not smoking behaviour. OUTCOMES: The critical outcome measure was abstinence from smoking six months or more after baseline, using the strictest measure of abstinence available at the longest follow-up. Prolonged or continuous abstinence was preferred over point prevalence. Our important outcome was the number of participants who made a quit attempt. RISK OF BIAS: Working independently, two review authors evaluated the risk of bias using the Cochrane RoB 1 tool, following guidance from the Cochrane Tobacco Addiction Group. SYNTHESIS

methodsWorking independently, two review authors extracted information about the characteristics of each included study (i.e. interventions, participants, outcomes, and methods). We pooled studies using random-effects meta-analysis where possible and otherwise summarised findings using narrative synthesis in text and tables. We used the GRADE framework to assess the certainty of the evidence. INCLUDED STUDIES: We included 29 studies in the review, published between 1989 and 2024. Together, the studies provided training for over 4030 health professionals, and data for 38,178 participants. We assessed 10 studies to have an overall low risk of bias, 17 an unclear risk, and two to have an overall high risk of bias. SYNTHESIS OF

resultsSixteen studies compared training of healthcare professionals in smoking cessation to no training, and assessed the effect on the number of participants abstinent at longest follow-up. High-certainty evidence indicates that smoking cessation training for healthcare professionals increases patient smoking cessation compared with no training (risk ratio (RR) 1.34, 95% confidence interval (CI) 1.08 to 1.67; I AUTHORS'

conclusionsHigh-certainty evidence supports the effectiveness of training health professionals in smoking cessation when compared with no training. Multi-component investigations incorporating new pharmacological interventions for smoking cessation (such as varenicline and bupropion) or other cessation aids alongside physician training should be considered to determine if any additional benefit in long-term abstinence can be obtained.

fundingProduction of this review was supported by PhD scholarship funding from the University of Adelaide and co-funded by Houd Research Group, awarded to KS. REGISTRATION: This review was first published outside of Cochrane in 1994 and subsequently updated as a Cochrane review in 2000 (DOI: 10.1002/14651858.CD000214) and 2012 (DOI: 10.1002/14651858.CD000214.pub2). No protocol was published or registered.

Indexed as

Health PersonnelSmoking CessationHumansRandomized Controlled Trials as Topic

Identifiers

PMID41676926
PMCPMC12895530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.